Literature DB >> 6150111

2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]-methyl] -1,4-benzoxathian: a new antagonist with high potency and selectivity toward alpha 1-adrenoreceptors.

C Melchiorre, L Brasili, D Giardinà, M Pigini, G Strappaghetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150111     DOI： 10.1021/jm00378a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

1.  Multiple alpha1-adrenergic receptor subtypes support synergistic stimulation of vasopressin and oxytocin release by ATP and phenylephrine.

Authors:  Zhilin Song; Dayane A Gomes; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-29       Impact factor: 3.619

2.  Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.

Authors:  A U Trendelenburg; C A Wahl; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells.

Authors:  L E Johnstone; C H Brown; H K Meeren; C L Vuijst; P J Brooks; G Leng; J A Russell
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

4.  Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat.

Authors:  C H Brown; N P Murphy; G Munro; M Ludwig; P M Bull; G Leng; J A Russell
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

5.  Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.